Dr. Valery Edwabny, MD, Vienna, Austria - OB/GYN, Gynecology, Obestetrics, Nutritional medicine, Alternative medicine, NuTron Test. Dr. Valery Edwabny, MD, Vienna, Austria - OB/GYN, Gynecology, Obestetrics, Nutritional medicine, Alternative medicine, NuTron Test.
Dr. Valery Edwabny, MD, Vienna, Austria - OB/GYN, Gynecology, Obestetrics, Nutritional medicine, Alternative medicine, NuTron Test.
German, English, Russian.
Gynaecology & Obstetrics
Nutritional medicine
NuTron Test
Alternative medicine
Proctology
Urology
Anti-Aging-Medicine
Treatment of wrinkles
Migraine
Laboratory
Dr. Valery Edwabny, MD - Wickenburggasse 19/12, 1080 Vienna, Austria
 
Home Links

Gynecology Menopause  Menopause

 
 
hormone therapy risk

More doubt
over hormone
therapy


Study: HRT dramatically increases risk of heart attack

 
 

BOSTON, Aug. 6, 2003

Two medical studies released Wednesday provided more damning evidence that giving female hormones to older women does little to improve their health and may in fact harm it.

The studies found that the treatments do not protect women from heart disease, as doctors once believed, and one of the studies found that giving hormones to women actually increases their risk of heart attack.

Both studies appeared in the New England Journal of Medicine, which published a separate piece of research earlier this year suggesting the health risks of estrogen and progestin treatments for older women outweigh the benefits.

In one study in this week’s Journal, a research team led by JoAnn Manson of Brigham and Women’s Hospital in Boston found that women taking estrogen and progestin increase their risk of a heart attack by 81 percent in the first year.

The findings, the researchers said, mean that most women who are taking the hormones should stop, and those who have reached menopause should not start.

“Overall, the risk of treatment outweighed the benefits during 5.6 years of treatment,” they concluded in their study.

Although hormone supplements may reduce the risk of hip fracture and colorectal cancer, they increase the likelihood of stroke by 41 percent, the longer-term risk of a heart attack by 29 percent, and the chance of breast cancer by 26 percent. The only remaining reason for prescribing the treatment is to relieve the symptoms of menopause, the Manson team said.

They ended their study of 16,608 women early once the dangers of hormone treatments became apparent.


Key points

For millions of women, the question of whether to take hormone replacement therapy after menopause just got more confusing. All the answers aren't in yet, but new findings suggest many of the 6 million American women who use estrogen and progestin should quit.

* If you're using the hormone combination in hopes it will protect your heart -- quit. Contrary to once-popular belief, the pills can actually harm the hearts of previously healthy women, the study found.

* If you're using HRT to prevent osteoporosis, at some point you should consider taking some of the other medications which have not been shown to increase the risk for breast cancer, such as raloxifene.

* If a woman has severe hot flashes and finds relief with HRT but now wants to stop, she ought to wean herself slowly over time -- it may take up to six months. But if one stops the supplements abruptly, the hot flashes may come back severely.

* These warnings don't apply to the 8 million more American women who use estrogen alone - a therapy restricted to those who've had hysterectomies because estrogen causes uterine cancer unless balanced by progestin. The NIH is letting a second, smaller study of those women continue for now, saying the risks and benefits remain unclear.

* The National Institutes of Health urges women taking hormones to talk with their doctors about what to do.


That produced a “nearly unshakable belief in the benefits of hormone therapy” in the absence of a real test of the treatment, said David Herrington and Timothy Howard of the Wake Forest University School of Medicine in Winston-Salem, North Carolina.

Even when studies, beginning in 1998, revealed there was no benefit, the belief was so ingrained the findings were heavily criticized and dismissed, Herrington and Howard wrote in an analysis in the Journal.

They said this case illustrates that animal tests and observational studies are no substitute for studies that use placebos and include large numbers of people.

© 2003 Reuters Limited